TMCnet News
Magellan Health to Participate at Nephron Research Pharma Pricing and Benefit Management SymposiumMagellan Health, Inc. (NASDAQ: MGLN) today announced that Mostafa Kamal, chief executive officer of Magellan (News - Alert) Rx Management, and Casey Stockman, vice president medical pharmacy for Magellan Rx Management, will participate in a panel discussion at the Nephron Research Pharma Pricing and Benefit Management Symposium on Thursday, April 12, 2018, at the Benjamin Hotel in New York. Panel members will discuss real world examples of managing the pharmacy spend covered under the medical benefit.
About Magellan Health: (MGLN-GEN)
View source version on businesswire.com: https://www.businesswire.com/news/home/20180328005553/en/ |